高血压糖尿病门诊用药支付新标准来了

Core Viewpoint - The Hunan Provincial Medical Insurance Bureau has issued a notification to establish a dynamic adjustment mechanism for the outpatient medication coverage and payment standards for hypertension and diabetes, ensuring comprehensive coverage for these conditions in urban and rural residents [1][2]. Group 1: Medication Coverage - The notification includes all medications for hypertension and diabetes, based on the previous year's standards and the National Basic Medical Insurance Drug Directory [1]. - Specific categories of hypertension medications (e.g., antihypertensives, diuretics, beta-blockers, calcium channel blockers, and renin-angiotensin system drugs) and diabetes medications are fully included in the coverage [1]. Group 2: Payment Standards - Payment standards for the medications have been recalculated based on national agreements and local procurement prices, ensuring uniformity across the province [2]. - Medications selected through national or provincial procurement will be marked with an asterisk for easy identification by healthcare providers and patients [2]. Group 3: Reimbursement and Accessibility - The reimbursement policy for hypertension and diabetes medications has been optimized, with a unified standard across Hunan, allowing residents to access benefits at local healthcare facilities [3]. - There is no threshold for reimbursement, with a uniform reimbursement rate of 70%. The annual payment limit for hypertension medications is set at 360 yuan, while for diabetes medications, it is 600 yuan, allowing a combined limit of 960 yuan for patients with both conditions [3].